Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1474020-03-5

5-((5-((4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-5-oxopentanamido)methyl)-2-((E)-(4-hydroxy-2-((13-oxo-17-((4S)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-3,6,9-trioxa-12-azaheptadecyl)oxy)phenyl)diazenyl)benzoic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1474020-03-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • 5-((5-((4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-5-oxopentanamido)methyl)-2-((E)-(4-hydroxy-2-((13-oxo-17-((4S)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-3,6,9-trioxa-12-azaheptadecyl)oxy)phenyl)diazenyl)benzoic acid

    Cas No: 1474020-03-5

  • Need to discuss

  • No requirement

  • Adequate

  • NINGBO ZHENHAI FELLOW CHEMICAL CO.,LTD
  • Contact Supplier

  • 5-((5-((4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-5-oxopentanamido)methyl)-2-((E)-(4-hydroxy-2-((13-oxo-17-((4S)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-3,6,9-trioxa-12-azaheptadecyl)oxy)phenyl)diazenyl)benzoic acid

    Cas No: 1474020-03-5

  • Need to discuss

  • No requirement

  • Adequate

  • Shanghai Norky Pharmaceutical Co., LTD.
  • Contact Supplier
  • 1474020-03-5 Structure

  • Basic information

    1. Product Name: 5-((5-((4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-5-oxopentanamido)methyl)-2-((E)-(4-hydroxy-2-((13-oxo-17-((4S)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-3,6,9-trioxa-12-azaheptadecyl)oxy)phenyl)diazenyl)benzoic acid
    2. Synonyms: 5-((5-((4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-5-oxopentanamido)methyl)-2-((E)-(4-hydroxy-2-((13-oxo-17-((4S)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-3,6,9-trioxa-12-azaheptadecyl)oxy)phenyl)diazenyl)benzoic acid
    3. CAS NO:1474020-03-5
    4. Molecular Formula:
    5. Molecular Weight: 972.092
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1474020-03-5.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 5-((5-((4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-5-oxopentanamido)methyl)-2-((E)-(4-hydroxy-2-((13-oxo-17-((4S)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-3,6,9-trioxa-12-azaheptadecyl)oxy)phenyl)diazenyl)benzoic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: 5-((5-((4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-5-oxopentanamido)methyl)-2-((E)-(4-hydroxy-2-((13-oxo-17-((4S)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-3,6,9-trioxa-12-azaheptadecyl)oxy)phenyl)diazenyl)benzoic acid(1474020-03-5)
    11. EPA Substance Registry System: 5-((5-((4-(1,2,4,5-tetrazin-3-yl)benzyl)amino)-5-oxopentanamido)methyl)-2-((E)-(4-hydroxy-2-((13-oxo-17-((4S)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-3,6,9-trioxa-12-azaheptadecyl)oxy)phenyl)diazenyl)benzoic acid(1474020-03-5)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1474020-03-5(Hazardous Substances Data)

1474020-03-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1474020-03-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,7,4,0,2 and 0 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1474020-03:
(9*1)+(8*4)+(7*7)+(6*4)+(5*0)+(4*2)+(3*0)+(2*0)+(1*3)=125
125 % 10 = 5
So 1474020-03-5 is a valid CAS Registry Number.

1474020-03-5Downstream Products

1474020-03-5Relevant articles and documents

Bioorthogonal approach to identify unsuspected drug targets in live cells

Yang, Katherine S.,Budin, Ghyslain,Tassa, Carlos,Kister, Olivier,Weissleder, Ralph

, p. 10593 - 10597 (2013/10/21)

A proteomics method to pull down secondary drug targets from live cells is described. The drug of interest is modified with trans-cyclooctene (TCO) and incubated with live cells. Upon cell lysis, the modified drug bound to the protein is pulled down using magnetic beads decorated with a cleavable tetrazine-modified linker. Samples are then run on an SDS-PAGE gel and isolated bands are submitted for mass spectrometry analysis to identify drug targets. Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1474020-03-5